Illinois, US-based software systems provider Wellspring Worldwide bagged $3.5 million in funding from undisclosed investors, according to a document filed with the US Securities and Exchange Commission.

As the New Year starts to roll, private equity firm Carlyle joins the other firms racing to make acquisitions with its $4.15 billion purchase of a Johnson&Johnson unit, the Financial Times reported.

After lackluster activity in the past years, pharmaceutical firms have gotten back to producing new drugs but they encounter challenges in selling them, according to a report on The Wall Street Journal.

California, US-based software developing company Accelrys has acquired Ireland-based software business Qumas in a deal valued at $50 million to expand its products expansion and client base.

Washington-based tech company Microsoft Corp sold a record offering of USD8 billion of bonds in dollars and euros to fund general corporate purposes, according to regulatory filings today.

Top credit ranking Johnson & Johnson reportedly sold USD3.5 billion in a six-part bond issue, its first offering in the last two years. Proceeds from the deal will be used to pay the health care product manufacturer's outstanding debt.

US-based generic drug manufacturer Mylan and two Indian pharmaceutical firms are in talks to buy Chennai-based Bafna Pharmaceuticals for an undisclosed amount, according to two sources familiar with the transaction.

Only three potential buyers from at least five who expressed initial interest were left to bid for the Ortho Clinical Diagnostics business of healthcare firm Johnson & Johnson, according to sources interviewed by Bloomberg.

Sources name the Carlyle Group LP and a combined group from Danaher Corp and Blackstone Group LP to have successfully advanced to the final stage of sale negotiations for J&J's diagnostics unit

Healthcare company Johnson & Johnson stopped selling some of its products to Amazon.com because of complaints about the site's third party sellers.